BICLUSTER_ID : UPREG-46
PATHOGENS /3/ : pseudomonas aeruginosa,listeria monocytogenes,ehrlichia chaffeensis
TARGETS /13/ : PLAT, LTB, CD40, PROCR, CYP1B1, IL3RA, IL6, AMPD3, IL1B, ISG20, CD55, TNF, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, RAB31, GBP1, PSCDBP, NMI, SOCS3, PMAIP1, CCL4, IER3, KLF6, DUSP5, LTB, GADD45G, PTPRC, SRC, LCP2, CD53, IL6, IL1B, CTSC, SLC7A5, CHSY1, UPP1, PLAUR, TNF, MX1
NETPATH IL 5 PATHWAY UPRHOH, DUSP5, TLR1, LTB, IL3RA, IL1B, CTSC, CD55, IER3
GERY CEBP TARGETSCXCL1, EREG, PLAT, KLF4, S100A8, PROCR, GADD45G, CD47, CXCL5, ATF3, PLAUR
NETPATH IL 1 PATHWAY UPCXCL5, NFKBIA, IL6, AMPD3, IL1B, CXCL1, CXCL2, CCL4
NETPATH IL 4 PATHWAY UPCEBPB, BCL2L11, CYP1B1, SOCS3, RASA2, IL6, IL1RN, CTSC, RIPK2, S100A9
NCI IL23PATHWAYSOCS3, NFKBIA, IL6, IL1B, CXCL1
NETPATH IL 4 PATHWAY DOWNNFKBIA, IL6, LTB, CXCL2
NETPATH B CELL RECEPTOR PATHWAY DOWNNFKBIA, DUSP5, CXCL1, ISG20, CD40, IRF7, PTPRC
NETPATH IL 3 PATHWAY UPSOCS3, IL1B, CCL4
NETPATH IL 6 PATHWAY UPSOCS3, MAFF, CXCL1, CEBPB, MAP3K8, TNF
NCI BCR 5PATHWAY
NETPATH IL 5 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
LINDGREN BLADDER CANCER CLUSTER 2B
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
CHEN LVAD SUPPORT OF FAILING HEART UP
NCI TNFPATHWAY
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ELVIDGE HYPOXIA UP
NETPATH T CELL RECEPTOR PATHWAY DOWN
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
AMIT EGF RESPONSE 480 HELA
MITSIADES RESPONSE TO APLIDIN UP
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
HASINA NOL7 TARGETS UP
REACTOME SIGNALING IN IMMUNE SYSTEM
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
MARTORIATI MDM4 TARGETS FETAL LIVER UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
XU HGF TARGETS INDUCED BY AKT1 48HR UP
VART KSHV INFECTION ANGIOGENIC MARKERS UP
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
DELYS THYROID CANCER UP
TSAI RESPONSE TO IONIZING RADIATION
KRISHNAN FURIN TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
AMIT EGF RESPONSE 120 HELA
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
MCLACHLAN DENTAL CARIES UP
WINTER HYPOXIA METAGENE
GAJATE RESPONSE TO TRABECTEDIN UP
BROWNE HCMV INFECTION 8HR UP
PODAR RESPONSE TO ADAPHOSTIN UP
HOSHIDA LIVER CANCER SUBCLASS S1
JAATINEN HEMATOPOIETIC STEM CELL DN
NCI CD8TCRPATHWAY
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
FARMER BREAST CANCER CLUSTER 1
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
HADDAD T LYMPHOCYTE AND NK PROGENITOR DN
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
NCI AMB2 NEUTROPHILS PATHWAY
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
BROWNE HCMV INFECTION 2HR UP
LEE LIVER CANCER MYC E2F1 UP
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
NCI P53DOWNSTREAMPATHWAY
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
ZHOU INFLAMMATORY RESPONSE FIMA UP
TIAN TNF SIGNALING VIA NFKB
GAL LEUKEMIC STEM CELL DN
HUMMEL BURKITTS LYMPHOMA DN
ZHU CMV ALL UP
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
GOLUB ALL VS AML DN
KEGG APOPTOSIS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
REACTOME TCR SIGNALING
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
LEONARD HYPOXIA
CHEN LVAD SUPPORT OF FAILING HEART DN
AUJLA IL22 AND IL17A SIGNALING
CROONQUIST STROMAL STIMULATION UP
LEE LIVER CANCER MYC TGFA UP
SA MMP CYTOKINE CONNECTION
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
KIM LRRC3B TARGETS
HORIUCHI WTAP TARGETS UP
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
MAHADEVAN RESPONSE TO MP470 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
BIOCARTA TH1TH2 PATHWAY
KEGG JAK STAT SIGNALING PATHWAY
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
NCI BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
NETPATH IL 6 PATHWAY
GILDEA METASTASIS
SEIKE LUNG CANCER POOR SURVIVAL
AMIT EGF RESPONSE 20 HELA
REACTOME INNATE IMMUNITY SIGNALING
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
WU SILENCED BY METHYLATION IN BLADDER CANCER
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
BIOCARTA BLYMPHOCYTE PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
NCI TCR PATHWAY
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
KEGG B CELL RECEPTOR SIGNALING PATHWAY
FRIDMAN SENESCENCE UP
CROMER TUMORIGENESIS UP
WU HBX TARGETS 2 DN
NETPATH B CELL RECEPTOR PATHWAY UP
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
KEGG LEISHMANIA INFECTION
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
MARKS HDAC TARGETS DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
MCLACHLAN DENTAL CARIES DN
ST T CELL SIGNAL TRANSDUCTION
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
SENESE HDAC1 AND HDAC2 TARGETS UP
ONDER CDH1 TARGETS 2 DN
RODWELL AGING KIDNEY UP
SENESE HDAC1 TARGETS UP
ZHAN MULTIPLE MYELOMA CD1 VS CD2 UP
LIU TARGETS OF VMYB VS CMYB DN
REACTOME TOLL RECEPTOR CASCADES
BREDEMEYER RAG SIGNALING VIA ATM NOT VIA NFKB UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KIM WT1 TARGETS UP
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
LIAN LIPA TARGETS 3M
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
MORI IMMATURE B LYMPHOCYTE UP
XU HGF SIGNALING NOT VIA AKT1 48HR UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
SMID BREAST CANCER RELAPSE IN BONE DN
SMID BREAST CANCER BASAL UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAMASHITA METHYLATED IN PROSTATE CANCER
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansaehrlichia chaffeensis wakullalisteria monocytogenespseudomonas aeruginosaGeneSet Name
0.00029 0.00006 0.00068 0.11013NETPATH_IL_2_PATHWAY_UP
0.00007 0.00000 0.00007 0.00238NETPATH_IL_5_PATHWAY_UP
0.01308 0.00116 0.00163 0.00843GERY_CEBP_TARGETS
0.00744 0.00022 0.00000 0.00004NETPATH_IL_1_PATHWAY_UP
0.00011 0.00000 0.00098 0.08967NETPATH_IL_4_PATHWAY_UP
0.00000 0.00020 0.00100 0.00049NCI_IL23PATHWAY
0.00001 0.00000 0.00001 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.00005 0.00901 0.06465NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00000 0.00000 0.00553 0.01596NETPATH_IL_3_PATHWAY_UP
0.00003 0.00000 0.00233 0.01244NETPATH_IL_6_PATHWAY_UP
0.06932 0.00101 0.01961 0.04142NCI_BCR_5PATHWAY
0.00785 0.00075 0.05769 0.11369NETPATH_IL_5_PATHWAY
0.00021 0.00547 0.00023 0.01558GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.06659 0.00699 0.08391 0.04067BIOCARTA_NFKB_PATHWAY
0.01198 0.00447 0.00046 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.01089 0.04046 0.01186 0.03347WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00000 0.00000 0.06578 0.09315LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00000 0.00000 0.00001 0.00016ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.04646 0.03586 0.03122 0.01543MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.14628 0.01382 0.06346 0.11056CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.16521 0.06530 0.03361 0.05234NCI_TNFPATHWAY
0.00000 0.00000 0.09679 0.09360TENEDINI_MEGAKARYOCYTE_MARKERS
0.00007 0.00000 0.00437 0.00005LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.17481 0.01394 0.00776 0.02041BIOCARTA_IL1R_PATHWAY
0.00307 0.00001 0.04054 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.00000 0.00387LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.03933 0.02903 0.00043 0.02390LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.01170 0.00027 0.00023 0.10177ELVIDGE_HYPOXIA_UP
0.00211 0.00007 0.01903 0.15620NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.03874 0.00042 0.00068 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00034 0.00004 0.09197 0.00151NETPATH_IL_7_PATHWAY_UP
0.00697 0.02739 0.15820 0.00150YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00155 0.01382 0.13545 0.11752MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.12490 0.00119 0.14707 0.00562AMIT_EGF_RESPONSE_480_HELA
0.09988 0.03497 0.00418 0.08410MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.00000 0.00000 0.10336BROWNE_INTERFERON_RESPONSIVE_GENES
0.00000 0.00000 0.03989 0.09153NCI_IL6_7PATHWAY
0.01384 0.00174 0.00000 0.00381THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.18351 0.14172 0.00843 0.17965HASINA_NOL7_TARGETS_UP
0.00000 0.00000 0.00228 0.04260REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00081 0.00001 0.00008 0.13363TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00000 0.00000 0.00005 0.02052LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.19874 0.13788 0.08063 0.10352MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.04656 0.08132 0.00030 0.10385TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00055 0.00001 0.00001 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.03945 0.11672 0.12454 0.13427KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00000 0.00000 0.00004 0.02176MARKEY_RB1_ACUTE_LOF_UP
0.00013 0.00000 0.00736 0.00004KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03910 0.03040 0.00837 0.00321DAZARD_UV_RESPONSE_CLUSTER_G3
0.12062 0.05349 0.04325 0.06674XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.02454 0.01577 0.01472 0.02603VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00000 0.00000 0.01422 0.00086DUTTA_APOPTOSIS_VIA_NFKB
0.11433 0.00777 0.03942 0.16056COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.00020 0.00000 0.05915 0.03069DELYS_THYROID_CANCER_UP
0.00169 0.00000 0.13958 0.03182TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00678 0.00348 0.04616 0.01934KRISHNAN_FURIN_TARGETS_UP
0.01934 0.00958 0.02652 0.19372TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.00000 0.00000 0.00199 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00007 0.00650 0.00068 0.01592DER_IFN_GAMMA_RESPONSE_UP
0.03630 0.01648 0.05773 0.13386NCI_NFAT_TFPATHWAY
0.01092 0.00039 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.02809 0.00507 0.00011 0.00003ONDER_CDH1_TARGETS_3_DN
0.07404 0.00037 0.02592 0.00184AMIT_EGF_RESPONSE_120_HELA
0.13021 0.06671 0.16188 0.00610HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.00000 0.00000 0.00001 0.01171NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00000 0.00000 0.00075 0.14139LIAN_LIPA_TARGETS_6M
0.01021 0.00276 0.01127 0.00593NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00000 0.00000 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.11984 0.01067 0.00186 0.10229WINTER_HYPOXIA_METAGENE
0.02606 0.00261 0.01700 0.08239GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.08926 0.13241 0.00128 0.10159BROWNE_HCMV_INFECTION_8HR_UP
0.00428 0.00028 0.00004 0.13378PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00000 0.00000 0.00003 0.15655HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00000 0.00000 0.04089 0.03113JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.01628 0.00041 0.10923 0.16035NCI_CD8TCRPATHWAY
0.00000 0.00000 0.00001 0.00185FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000 0.00001 0.00036GAURNIER_PSMD4_TARGETS
0.00000 0.00000 0.07324 0.17408HELLER_SILENCED_BY_METHYLATION_UP
0.00000 0.00000 0.00001 0.03450FARMER_BREAST_CANCER_CLUSTER_1
0.02810 0.04099 0.03199 0.01071SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00000 0.00000 0.06328 0.18908HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.04059 0.11655 0.00123 0.01390NETPATH_TNF_ALPHA_PATHWAY_UP
0.00000 0.00000 0.00005 0.05916MARKEY_RB1_CHRONIC_LOF_DN
0.00000 0.00000 0.00011 0.00725ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00021 0.00002 0.18259 0.00645NCI_AMB2_NEUTROPHILS_PATHWAY
0.00000 0.00000 0.12803 0.04524SMID_BREAST_CANCER_LUMINAL_B_DN
0.00269 0.00012 0.00000 0.00043ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00047 0.00032 0.02216 0.00178GESERICK_TERT_TARGETS_DN
0.00946 0.00014 0.14664 0.03351KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.15614 0.11885 0.02059 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.00000 0.00000 0.02477 0.16348LEE_LIVER_CANCER_MYC_E2F1_UP
0.17152 0.01412 0.00002 0.00703SESTO_RESPONSE_TO_UV_C3
0.00000 0.00000 0.00000 0.00267VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.06408 0.01188 0.15374 0.00321AMIT_EGF_RESPONSE_40_MCF10A
0.02731 0.01485 0.07287 0.06355REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00175 0.00022 0.00027 0.00051GEISS_RESPONSE_TO_DSRNA_UP
0.00015 0.00030 0.00032 0.02559GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.07476 0.03452 0.14599 0.04260NCI_P53DOWNSTREAMPATHWAY
0.00221 0.00050 0.07166 0.00537SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.09979 0.02576 0.00125 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00003 0.00000 0.00054 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.00000 0.00000 0.05920 0.19123GAL_LEUKEMIC_STEM_CELL_DN
0.00212 0.00020 0.17259 0.00598HUMMEL_BURKITTS_LYMPHOMA_DN
0.00053 0.00083 0.00000 0.13854ZHU_CMV_ALL_UP
0.00000 0.00000 0.02242 0.00027KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03261 0.01955 0.01375 0.03983GOLUB_ALL_VS_AML_DN
0.04003 0.00860 0.08467 0.06634KEGG_APOPTOSIS
0.00021 0.00011 0.02848 0.00093LEE_LIVER_CANCER_HEPATOBLAST
0.00040 0.00000 0.00001 0.00102NAGASHIMA_EGF_SIGNALING_UP
0.11440 0.00462 0.00200 0.04481AMIT_DELAYED_EARLY_GENES
0.00244 0.00003 0.00795 0.10133REACTOME_TCR_SIGNALING
0.02646 0.00070 0.01523 0.00367AMIT_EGF_RESPONSE_60_MCF10A
0.00358 0.00151 0.00031 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00610 0.00170 0.00045 0.03016RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.01772 0.00340 0.02668 0.06631NOJIMA_SFRP2_TARGETS_UP
0.00000 0.00000 0.02915 0.00066KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00123 0.00006 0.00001 0.00002MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00021 0.00000 0.00015 0.02594SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00488 0.00301 0.00001 0.00003OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.01232 0.00008 0.00328 0.09020LEONARD_HYPOXIA
0.04644 0.03472 0.01521 0.09879CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.00697 0.01045 0.00510 0.04032AUJLA_IL22_AND_IL17A_SIGNALING
0.00000 0.00000 0.05925 0.01456CROONQUIST_STROMAL_STIMULATION_UP
0.00006 0.00000 0.00938 0.17247LEE_LIVER_CANCER_MYC_TGFA_UP
0.00037 0.00000 0.04438 0.04053SA_MMP_CYTOKINE_CONNECTION
0.00000 0.00000 0.00031 0.03564WALLACE_PROSTATE_CANCER_RACE_UP
0.00127 0.00451 0.09742 0.00003SAGIV_CD24_TARGETS_DN
0.00000 0.00017 0.00001 0.03852KIM_LRRC3B_TARGETS
0.00147 0.00059 0.01805 0.10214HORIUCHI_WTAP_TARGETS_UP
0.15904 0.02715 0.00298 0.04274GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.06062 0.00376 0.05928 0.19524ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.18500 0.08720 0.01146 0.00187MAHADEVAN_RESPONSE_TO_MP470_DN
0.00000 0.00022 0.07558 0.06176CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00111 0.00009 0.02563 0.07170BIOCARTA_TH1TH2_PATHWAY
0.01019 0.00097 0.17844 0.19708KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00160 0.00025 0.00000 0.00391HARRIS_HYPOXIA
0.02531 0.00015 0.05671 0.05123NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.06939 0.05094 0.08192 0.04046NCI_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS
0.01570 0.02669 0.04308 0.08417KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.17299 0.04314 0.06270 0.07441NETPATH_IL_6_PATHWAY
0.00611 0.00141 0.14957 0.13362GILDEA_METASTASIS
0.01151 0.00714 0.00438 0.09189SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00013 0.00184 0.02894 0.00091AMIT_EGF_RESPONSE_20_HELA
0.01515 0.00826 0.02146 0.02510REACTOME_INNATE_IMMUNITY_SIGNALING
0.00053 0.00000 0.00061 0.09083TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.02806 0.00136 0.01520 0.11257WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.09168 0.01034 0.00399 0.00906KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.00000 0.00020 0.00006BASSO_CD40_SIGNALING_UP
0.09628 0.00264 0.01298 0.05837TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00648 0.00000 0.00045 0.00113NAGASHIMA_NRG1_SIGNALING_UP
0.00003 0.00027 0.09270 0.00251SOUCEK_MYC_TARGETS
0.00871 0.00448 0.08039 0.13404BIOCARTA_BLYMPHOCYTE_PATHWAY
0.17707 0.01086 0.00142 0.00023TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00213 0.00000 0.09033 0.11273NCI_TCR_PATHWAY
0.07345 0.11589 0.05033 0.08983ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00434 0.00010 0.17037 0.06142WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.00262 0.00002 0.12277 0.00559KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00696 0.00628 0.15020 0.07194FRIDMAN_SENESCENCE_UP
0.12793 0.08461 0.01616 0.00771CROMER_TUMORIGENESIS_UP
0.02731 0.00094 0.00791 0.04253WU_HBX_TARGETS_2_DN
0.01457 0.00122 0.03363 0.10186NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00029 0.00001 0.00004 0.00009MAHADEVAN_RESPONSE_TO_MP470_UP
0.00947 0.00156 0.06128 0.00003FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.01590 0.00829 0.07253 0.01521BIOCARTA_TID_PATHWAY
0.00000 0.00000 0.00228 0.16256FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.00696 0.00024 0.00000 0.00110BILD_HRAS_ONCOGENIC_SIGNATURE
0.00001 0.00000 0.00001 0.00126LIANG_SILENCED_BY_METHYLATION_2
0.01097 0.00307 0.00016 0.00006DAUER_STAT3_TARGETS_UP
0.00000 0.00000 0.00055 0.00366KEGG_LEISHMANIA_INFECTION
0.05909 0.00102 0.02795 0.17983AMIT_EGF_RESPONSE_60_HELA
0.02809 0.03269 0.03814 0.02053ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00705 0.00358 0.03353 0.00379BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.06022 0.00632 0.01133 0.07473MARKS_HDAC_TARGETS_DN
0.01709 0.00291 0.00000 0.00776CHEN_HOXA5_TARGETS_9HR_UP
0.03944 0.00111 0.04745 0.01158DAZARD_UV_RESPONSE_CLUSTER_G2
0.00000 0.00000 0.00000 0.00005MCLACHLAN_DENTAL_CARIES_DN
0.00277 0.00064 0.05774 0.00428ST_T_CELL_SIGNAL_TRANSDUCTION
0.00705 0.00005 0.00799 0.00028AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00007 0.00003 0.00097 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.06066 0.01806 0.00060 0.00121CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.04213 0.03615 0.06782 0.13355WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.00000 0.00000 0.02114ZHU_CMV_8_HR_UP
0.03251 0.02732 0.05971 0.00508BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.03146 0.00595 0.00012 0.08424BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.15854 0.01080 0.00023 0.03137SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00757 0.00036 0.00554 0.00503ONDER_CDH1_TARGETS_2_DN
0.00000 0.00000 0.11822 0.00266RODWELL_AGING_KIDNEY_UP
0.09820 0.03717 0.00009 0.16126SENESE_HDAC1_TARGETS_UP
0.02027 0.00529 0.01420 0.03170ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.03006 0.00731 0.05670 0.03971LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00786 0.00067 0.10475 0.02046REACTOME_TOLL_RECEPTOR_CASCADES
0.11753 0.08705 0.15285 0.07004BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.00262 0.00004 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.13365 0.00017 0.01564 0.00318KIM_WT1_TARGETS_UP
0.02300 0.00161 0.00698 0.19677PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.00000 0.00000 0.00018 0.12753LIAN_LIPA_TARGETS_3M
0.00086 0.00340 0.00309 0.12436VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.01044 0.00252 0.00588 0.00006KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.02814 0.00336 0.00007 0.00002UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.01646 0.00063 0.00146 0.00180XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00000 0.00000 0.00266 0.17360MORI_IMMATURE_B_LYMPHOCYTE_UP
0.00356 0.00001 0.00850 0.04449XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00000 0.00000 0.00001 0.15886HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.14492 0.03956 0.00595 0.00000DASU_IL6_SIGNALING_UP
0.04510 0.00131 0.00142 0.03582ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00001 0.00009 0.00001 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05925 0.06016 0.06660 0.06637GOUYER_TATI_TARGETS_UP
0.00511 0.00265 0.00001 0.00003OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.10538 0.00899 0.00518 0.00002ZUCCHI_METASTASIS_DN
0.10827 0.10522 0.17026 0.19699SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.00921 0.00078 0.14974 0.18445SMID_BREAST_CANCER_BASAL_UP
0.07569 0.00099 0.01526 0.00151PRAMOONJAGO_SOX4_TARGETS_UP
0.05114 0.00107 0.00887 0.04258PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.06398 0.02573 0.09035 0.15907YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.18992 0.04364 0.06387 0.09212YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.19587 0.02901 0.05106 0.03006LU_TUMOR_ENDOTHELIAL_MARKERS_UP